Frontier Capital Management CO LLC Halozyme Therapeutics, Inc. Transaction History
Frontier Capital Management CO LLC
- $9.96 Billion
- Q3 2024
A detailed history of Frontier Capital Management CO LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 1,269,827 shares of HALO stock, worth $72.8 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
1,269,827
Previous 846,227
50.06%
Holding current value
$72.8 Million
Previous $44.3 Million
63.96%
% of portfolio
0.73%
Previous 0.46%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
541Shares Held
123MCall Options Held
395KPut Options Held
172K-
Black Rock Inc. New York, NY17.6MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$739 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$380 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$233 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$195 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.99B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...